EVE and beyond, retro and prospective insights.
Our work has focused on the discovery that an endogenous vascular elastase (EVE) plays a pivotal role in the vascular changes associated with the development and progression of pulmonary hypertension. Recent studies have identified serum factors that stimulate transcription of this enzyme and have elucidated a signal transduction process involving activation of the mitogen-activated protein kinase pathway and nuclear expression of the transcription factor AML1. Proteases release and activate growth factors that are bound to the extracellular matrix and also induce, in a beta(3)-integrin-dependent manner, the transcription of the gene for the matrix glycoprotein tenascin. Tenascin alters smooth muscle cell shape and facilitates the proliferative response to growth factors by clustering and activating growth factor receptors. In addition, breakdown products of elastin, elastin peptides, can upregulate the production of fibronectin, a glycoprotein that is critical to smooth muscle cell migration. The mechanisms regulating enhanced fibronectin production have recently been successfully targeted to prevent the development of intimal lesions.
Division of Cardiovascular Research, Hospital for Sick Children, Toronto, Ontario, Canada M5G 1X8. mr@sickkids.on.ca
M
M
Rabinovitch
D000818:Animals; D001158:Arteries; D001808:Blood Vessels / Q000201:enzymology*; D002465:Cell Movement / Q000502:physiology; D005353:Fibronectins / Q000502:physiology; D006801:Humans; D006976:Hypertension, Pulmonary / Q000503:physiopathology; D009131:Muscle, Smooth, Vascular / Q000166:cytology; D010196:Pancreatic Elastase / Q000502:physiology*; D019063:Tenascin / Q000502:physiology; D014652:Vascular Diseases / Q000503:physiopathology
D005353:Fibronectins; D019063:Tenascin; D010196:Pancreatic Elastase